News Image

CAMECO CORP (NYSE:CCJ) Reports Q3 Earnings Miss, Highlights Transformative Partnership

By Mill Chart

Last update: Nov 5, 2025

CAMECO CORP (NYSE:CCJ) reported third-quarter financial results that fell short of analyst expectations on the top and bottom lines, though the company highlighted strong year-to-date performance and a transformative strategic partnership that signals long-term growth potential.

Earnings and Revenue Miss

For the quarter ended September 30, 2025, the uranium producer reported revenue of $630.7 million, which came in below the analyst consensus estimate of $737.0 million. The company's adjusted earnings per share (EPS) of $0.07 also missed the market's forecast of $0.31 per share.

Key financial results versus estimates:

  • Reported Revenue: $630.7 million
  • Estimated Revenue: $737.0 million
  • Reported Adjusted EPS: $0.07
  • Estimated EPS: $0.31

The lower-than-expected results were primarily attributed to decreased sales volumes in both its uranium and fuel services segments during the quarter, despite noting improvements in its average realized prices.

Market Reaction and Price Action

The market's initial reaction to the earnings miss appears mixed. In pre-market trading, the stock showed significant strength, climbing approximately 1.9%. This positive movement suggests that investors may be looking beyond the quarterly miss and focusing on the company's strategic developments and full-year guidance.

Near-term performance metrics:

  • Pre-market performance: +1.9%
  • Last week's performance: -9.3%
  • Last two weeks' performance: +17.1%
  • Last month's performance: +12.1%

Operational Highlights and Strategic Developments

Despite the quarterly earnings miss, Cameco's report contained several positive operational and strategic highlights. The company reported a strong balance sheet with $779 million in cash and cash equivalents and a manageable debt load of $1.0 billion.

The most significant announcement was a transformative partnership with Brookfield Asset Management and the U.S. Government to accelerate the deployment of Westinghouse nuclear reactors in the United States. This collaboration involves an aggregate investment value of at least $80 billion and is expected to create significant growth opportunities for both Westinghouse and Cameco.

Other notable developments from the quarter:

  • Year-to-date net earnings of $391 million and adjusted EBITDA of $1.3 billion showed substantial improvement over 2024
  • The company declared an accelerated annual dividend of $0.24 per common share
  • Received a $171.5 million distribution from its Westinghouse investment in October
  • Maintained strong contracting positions with over 28 million pounds of uranium under contract for average annual delivery over the next five years

Forward Outlook and Analyst Estimates

While Cameco narrowed its 2025 uranium delivery guidance to 32-34 million pounds, the company did not provide specific revenue or EPS guidance for the coming quarters. This leaves investors to consider the analyst estimates for context.

Current analyst projections for future periods:

  • Q4 2025 Estimated Revenue: $1.04 billion
  • Q4 2025 Estimated EPS: $0.40
  • Full-Year 2025 Estimated Revenue: $3.48 billion
  • Full-Year 2025 Estimated EPS: $1.55

The company's ability to meet these future estimates will depend on its execution amid production adjustments, including reduced output expectations from its McArthur River/Key Lake operations, which it expects to partially offset through increased production at Cigar Lake.

Conclusion

Cameco's third-quarter performance disappointed on key earnings metrics, but the market's reaction indicates investors are focusing on the company's strategic positioning in the growing nuclear energy sector. The transformative U.S. government partnership for Westinghouse reactor deployment represents a significant long-term growth driver that may outweigh near-term earnings volatility. The company's strong contract book, improved year-to-date financial performance, and exposure to strengthening uranium market fundamentals provide a solid foundation as it navigates operational challenges.

For detailed earnings estimates and future projections, view the complete earnings analysis for Cameco.

Disclaimer: This article is for informational purposes only and does not constitute investment advice, financial analysis, or a recommendation to buy or sell any security. The information presented is based on publicly available data and should not be relied upon as the sole basis for investment decisions. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions.

CAMECO CORP

NYSE:CCJ (11/4/2025, 8:06:06 PM)

Premarket: 97.75 +0.8 (+0.83%)

96.95

-3.9 (-3.87%)



Find more stocks in the Stock Screener

CCJ Latest News and Analysis

Follow ChartMill for more